KWM
NVCR icon

Kingsview Wealth Management’s NovoCure NVCR Stock Holding History

Kingsview Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,326
Closed -$387K – 985
2023
Q2 		$387K Sell
9,326
-1,477
-14% -$91.7K 0.02% 659
2023
Q1 		$650K Buy
10,803
+243
+2% +$19.4K 0.03% 505
2022
Q4 		$775K Sell
10,560
-97
-0.9% -$7.3K 0.03% 403
2022
Q3 		$810K Sell
10,657
-85
-0.8% -$6.63K 0.04% 379
2022
Q2 		$747K Sell
10,742
-930
-8% -$70.1K 0.04% 443
2022
Q1 		$967K Buy
11,672
+513
+5% +$37.8K 0.04% 404
2021
Q4 		$838K Sell
11,159
-764
-6% -$76.7K 0.03% 449
2021
Q3 		$1.39M Buy
11,923
+102
+0.9% +$15.4K 0.07% 294
2021
Q2 		$2.24M Sell
11,821
-38
-0.3% -$7.39K 0.11% 201
2021
Q1 		$1.58M Sell
11,859
-1,533
-11% -$242K 0.09% 231
2020
Q4 		$2.32M Buy
13,392
+653
+5% +$89.4K 0.17% 139
2020
Q3 		$1.42M Sell
12,739
-850
-6% -$68K 0.13% 170
2020
Q2 		$806K Sell
13,589
-5,878
-30% -$387K 0.08% 242
2020
Q1 		$1.31M Buy
19,467
+4,138
+27% +$327K 0.18% 145
2019
Q4 		$1.29M Buy
15,329
+1,344
+10% +$108K 0.16% 164
2019
Q3 		$1.05M Sell
13,985
-930
-6% -$74.4K 0.16% 155
2019
Q2 		$943K Sell
14,915
-285
-2% -$14.4K 0.16% 159
2019
Q1 		$732K Buy
+15,200
New +$732K 0.11% 215

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Kingsview Wealth Management's NVCR Position: Q3 2023 in Review

Kingsview Wealth Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 9,326 shares — an estimated $387K sold.

Kingsview Wealth Management first reported a position in NVCR in Q1 2019 and held it in 18 quarters. The position peaked at $2.32M in Q4 2020. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Kingsview Wealth Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Kingsview Wealth Management sold 9,326 NovoCure shares in Q3 2023, an estimated $387K.
  • Kingsview Wealth Management first reported a position in NovoCure in Q1 2019 and held it in 18 quarters.
  • Kingsview Wealth Management's NovoCure position peaked at $2.32M in Q4 2020.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Kingsview Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.